Rankings
▼
Calendar
TMDX Q2 2024 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena
TMDX
TransMedics Group, Inc.
$5B
Q2 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$114M
+117.9% YoY
Gross Profit
$69M
60.5% margin
Operating Income
$13M
10.9% margin
Net Income
$12M
10.7% margin
EPS (Diluted)
$0.35
QoQ Revenue Growth
+18.0%
Cash Flow
Operating Cash Flow
$26M
Free Cash Flow
$2M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$759M
Total Liabilities
$569M
Stockholders' Equity
$190M
Cash & Equivalents
$363M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$114M
$52M
+117.9%
Gross Profit
$69M
$37M
+88.2%
Operating Income
$13M
-$906,000
+1480.6%
Net Income
$12M
-$1M
+1318.2%
Revenue Segments
Product
$72M
63%
Service
$43M
37%
← FY 2024
All Quarters
Q3 2024 →